| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |